QuantaLife, a US-based technology company for human genomics, has raised $17.2m in its series B round from a consortium including Mérieux Développement, the corporate venturing company of Institut Mérieux, a French industrial holding company. Venture capital firm Paladin Capital Group led the round, and was joined by peer Vital Financial, as well as Mérieux. Paladin…
The rest of this content is only accessible to Global Venturing Subscribers.
This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.
